Metallothionein protects against the nephrotoxicity produced by chronic CdMT exposure
Authors:
Open Access
- 1 August 1999
- journal article
- research article
- Published by Oxford University Press (OUP) in Toxicological Sciences
- Vol. 50 (2) , 221-227
Abstract
Metallothionein (MT) is a low-molecular-weight, cysteine-rich, metal-binding protein. Induction of MT has been proposed to be an important adaptive mechanism in decreasing Cd toxicity. MT has been shown to protect against CdCl2-induced lethality and hepatotoxicity; however, MT does not protect against acute CdMT-induced nephrotoxicity. This study was aimed at clarifying the role of metallothionein in chronic CdMT-induced renal injury. Wild type and MT-I/II knockout (MT-null) mice were therefore given sc injections of CdMT (25 and 100 microg Cd/kg) or saline daily, 6 times/week for 6 weeks, and renal injury was evaluated. Multiple injections of CdMT to wild-type mice resulted in renal Cd concentrations up to 120 microg/g kidney, along with a 100-fold increase in renal MT (450 microg/g kidney). In contrast, renal Cd concentration in MT-null mice administered multiple injections of CdMT reached a much lower level than in wild-type mice (<10 microg/g kidney). Although less Cd accumulated in their kidneys, MT-null mice were more susceptible than wild-type mice to CdMT-induced nephrotoxicity, as indicated by increased urinary excretion of protein and N-acetyl-beta-D-glucosaminidase, as well as by elevated blood urea nitrogen levels. At the higher daily dose of CdMT (100 microg Cd/kg), kidneys of MT-null mice were enlarged. Chronic CdMT administration eventually damaged the entire kidney, which included glomerular swelling, interstitial inflammation, edema, tubular cell degeneration, and atrophy. In contrast to a single injection of CdMT that produces proximal tubular necrosis, chronic injection of CdMT results in tubular cell apoptosis in both wild-type and MT-null mice. These data indicate that chronic CdMT administration produces similar renal injury to that observed after chronic CdCl2 administration, and that intracellular MT protects against nephrotoxicity produced by chronic CdMT administration.Keywords
This publication has 19 references indexed in Scilit:
- Renal Accumulation of Cadmium and Nephropathy Following Long-Term Administration of Cadmium-MetallothioneinToxicology and Applied Pharmacology, 1996
- Transgenic Mice That Overexpress Metallothionein-I Are Protected from Cadmium Lethality and HepatotoxicityToxicology and Applied Pharmacology, 1995
- Discrepancy between the Nephrotoxic Potencies of Cadmium-Metallothionein and Cadmium Chloride and the Renal Concentration of Cadmium in the Proximal Convoluted TubulesToxicology and Applied Pharmacology, 1995
- Targeting and germ-line transmission of a null mutation at the metallothionein I and II loci in mouse.Proceedings of the National Academy of Sciences, 1993
- Renal cadmium deposition and injury as a result of accumulation of cadmium-metallothionein (CdMT) by the proximal convoluted tubules—A light microscopic autoradiography study with 109CdMTToxicology and Applied Pharmacology, 1992
- Non-metallothionein-bound cadmium in the pathogenesis of cadmium nephrotoxicity in the ratToxicology and Applied Pharmacology, 1989
- Rat kidney epithelial cell culture for metal toxicity studiesIn Vitro Cellular & Developmental Biology, 1985
- Cadmium-Metallothionein nephropathy: relationships between ultrastructural/biochemical alterations and intracellular cadmium binding.The Journal of Pharmacology and Experimental Therapeutics, 1984
- Altered subcellular distribution of cadmium following cadmium pretreatment: Possible mechanism of tolerance to cadmium-induced lethalityToxicology and Applied Pharmacology, 1983
- Evaluation of the Cd/hemoglobin affinity assay for the rapid determination of metallothionein in biologival tissuesToxicology and Applied Pharmacology, 1982